The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia

BackgroundArtemisinin combination therapy (ACT) is now the recommended first-line treatment for falciparum malaria throughout the world. Initiatives to eliminate malaria are critically dependent on its efficacy. There is recent worrying evidence that artemisinin resistance has arisen on the Thai-Cambodian border. Urgent containment interventions are planned and about to be executed. Mathematical modeling approaches to intervention design are now integrated into the field of malaria epidemiology and control. The use of such an approach to investigate the likely effectiveness of different containment measures with the ultimate aim of eliminating artemisinin-resistant malaria is described.MethodsA population dynamic mathematical modeling framework was developed to explore the relative effectiveness of a variety of containment interventions in eliminating artemisinin-resistant malaria in western Cambodia.ResultsThe most effective intervention to eliminate artemisinin-resistant malaria was a switch of treatment from artemisinin monotherapy to ACT (mean time to elimination 3.42 years (95% CI 3.32–3.60 years). However, with this approach it is predicted that elimination of artemisinin-resistant malaria using ACT can be achieved only by elimination of all malaria. This is because the various forms of ACT are more effective against infections with artemisinin-sensitive parasites, leaving the more resistant infections as an increasing proportion of the dwindling parasite population.ConclusionContainment of artemisinin-resistant malaria can be achieved by elimination of malaria from western Cambodia using ACT. The "last man standing" is the most resistant and thus this strategy must be sustained until elimination is truly achieved.

[1]  Renuka Kunte,et al.  WHO Guidelines for the treatment of malaria , 2011 .

[2]  R. Maude,et al.  The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?) , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[4]  Arjen Dondorp,et al.  Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial , 2005, The Lancet.

[5]  P. Ringwald,et al.  Efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia , 2006, Tropical medicine & international health : TM & IH.

[6]  P. Rathod,et al.  Variations in frequencies of drug resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Verdrager Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. , 1986, The Journal of tropical medicine and hygiene.

[8]  K. Mendis,et al.  A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. , 2007, The American journal of tropical medicine and hygiene.

[9]  Anne Mills,et al.  Access to artemisinin combination therapy for malaria in remote areas of Cambodia , 2008, Malaria Journal.

[10]  P. Ringwald,et al.  Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia , 2006, Tropical medicine & international health : TM & IH.

[11]  N. White,et al.  Qinghaosu (Artemisinin): The Price of Success , 2008, Science.

[12]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[13]  N. Khim,et al.  Large-scale malaria survey in Cambodia: Novel insights on species distribution and risk factors , 2007, Malaria Journal.